Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan Mahony currently holds 829 shares of Horizon Therapeutics Public Ltd Co (HZNP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Mahony has been a net seller of HZNP stock. They have purchased $0 and sold $13.4M worth of shares.
Susan Mahony's most recent insider trade was on Jun 10, 2026, when they sold 300 shares at $246.18 per share.
Susan Mahony serves as Executive at Horizon Therapeutics Public Ltd Co (HZNP). They have executed 76 insider transactions totaling $13.4M over their tenure at the company.
Susan Mahony holds the position of Executive at Horizon Therapeutics Public Ltd Co, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Susan Mahony has shown a selling trading pattern, with $0 in total purchases and $13.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Susan Mahony was on Dec 4, 2017, when they sold $3.2M worth of LLY shares. This transaction involved 36,585 shares at $86.18 per share.
Susan Mahony currently owns 829 shares of Horizon Therapeutics Public Ltd Co (HZNP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan Mahony's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan Mahony has 76 Form 4 filings on record as an insider at Horizon Therapeutics Public Ltd Co.
Set alerts for Susan Mahony and 40,000+ other insiders.